IRIS
ZICHE, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.752
EU - Europa 10.379
AS - Asia 1.944
AF - Africa 45
OC - Oceania 19
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 25.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.724
GB - Regno Unito 3.420
IE - Irlanda 1.767
CN - Cina 1.276
UA - Ucraina 1.231
SE - Svezia 1.016
RU - Federazione Russa 652
IT - Italia 600
DE - Germania 596
FR - Francia 589
SG - Singapore 331
FI - Finlandia 327
VN - Vietnam 111
IN - India 98
TR - Turchia 75
BE - Belgio 43
ES - Italia 43
CI - Costa d'Avorio 31
CA - Canada 24
AU - Australia 15
NL - Olanda 13
CZ - Repubblica Ceca 9
HK - Hong Kong 9
RO - Romania 8
AT - Austria 7
BG - Bulgaria 7
BR - Brasile 7
PL - Polonia 7
EE - Estonia 6
EU - Europa 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
GR - Grecia 5
LT - Lituania 5
IL - Israele 4
JP - Giappone 4
KG - Kirghizistan 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
EG - Egitto 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AM - Armenia 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BY - Bielorussia 2
CH - Svizzera 2
CY - Cipro 2
HR - Croazia 2
KR - Corea 2
MA - Marocco 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IQ - Iraq 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MX - Messico 1
MZ - Mozambico 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
SD - Sudan 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 25.157
Salva come PNG Salva come JPEG
Città #
Southend 3.222
Fairfield 1.981
Dublin 1.754
Chandler 1.068
Ashburn 1.058
Jacksonville 1.004
Woodbridge 939
Houston 875
Seattle 789
Wilmington 779
Cambridge 679
Ann Arbor 464
Princeton 363
Nanjing 310
Beijing 236
Santa Clara 231
Singapore 223
Siena 204
Boardman 159
San Diego 151
Menlo Park 148
Nanchang 125
Helsinki 120
San Mateo 115
Dong Ket 108
Fremont 101
Pune 81
Tianjin 77
Moscow 74
Shenyang 73
Kunming 63
Izmir 60
Hebei 52
Brussels 43
Changsha 41
Florence 39
Dearborn 37
Jinan 37
Málaga 36
Norwalk 35
London 33
Abidjan 31
Jiaxing 30
Shanghai 30
Falls Church 29
Rome 29
Lancaster 28
New York 27
Düsseldorf 26
Redwood City 26
Zhengzhou 25
San Francisco 24
Hangzhou 22
Columbus 19
Toronto 19
Los Angeles 18
Ningbo 18
Taizhou 18
Changchun 17
Milan 13
Lanzhou 12
Prato 12
Renton 12
Munich 11
Tappahannock 11
Frankfurt am Main 10
Guangzhou 10
Amsterdam 9
Anguillara Sabazia 9
Berlin 9
Mestre 9
Venezia 9
Kocaeli 8
Phoenix 8
Dallas 7
Hounslow 7
Melbourne 7
Sofia 7
Atlanta 6
Canberra 6
Chicago 6
Edinburgh 6
Falkenstein 6
Kilburn 6
Madrid 6
Tallinn 6
Vienna 6
Warsaw 6
Washington 6
Delhi 5
Indiana 5
New Bedfont 5
Rende 5
Saint Petersburg 5
Acton 4
Auckland 4
Avezzano 4
Bishkek 4
Bonndorf 4
Clifton 4
Totale 18.718
Salva come PNG Salva come JPEG
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 331
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 295
A fucose-containing O-glycoepitope on bovine and human nucleolin 233
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 230
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 217
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 205
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 194
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 193
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 193
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 184
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 183
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 182
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 180
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 179
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. 171
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 171
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 170
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 170
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 169
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 168
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 167
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects 164
Studying vascular angiogenesis and senescence in zebrafish embryos 162
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 159
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 158
The rabbit corneal pocket assay 155
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 153
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 153
Differential contribution of bradykinin receptors in angiogenesis 151
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 151
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 150
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 150
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 150
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 150
Assessing vascular senescence in zebrafish. 149
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells 148
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 148
Divergent effects of quercetin conjugates on angiogenesis 146
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 146
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 146
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 145
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 142
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases 141
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 135
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 135
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 134
In vitro and in vivo activation of endothelial cells by colony-stimulating factors 134
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 133
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis 133
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 132
Analysis of the role of chemokines in angiogenesis 131
Role of prostaglandin E1 and copper in angiogenesis 131
The corneal pocket assay 129
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 128
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 128
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 128
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 126
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 126
The effect of thiorphan on release of sensory neuropeptides from guinea-pig cerebral venous sinuses 124
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 124
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 124
NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins 124
Role of nitric oxide in the modulation of angiogenesis 123
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 123
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 123
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth 122
Absence of PAF actions increases angiogenesis 121
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 121
Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium 121
Biological characterization of nanocomposite hydrogels 121
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 121
In vitro and in vivo models to study chemokine regulation of angiogenesis 120
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 120
Pyridoxamine as inhibitor of the blood plasma benzylamine oxidase and other copper-containing amine oxidases 119
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 118
Nitric oxide in tumor angiogenesis 117
Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis. 117
Influence of lithium on mammary tumor growth in vivo 117
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability 117
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis 116
Ceruloplasmin, copper ions, and angiogenesis. 116
Gangliosides, copper ions and angiogenic capacity of adult tissues 116
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 115
Nitric oxide and angiogenesis 115
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit 115
Copper-dependent amine oxidases in angiogenesis induced by prostaglandin E1 (PGE1) 115
Vimentin expression influences flow dependent VASP phosphorylation and regulates cell migration and proliferation. 114
ETB receptors promote proliferation and migration of endothelial cells 114
Effects of substance P on mesenteric lymphatic contractility in the rat 113
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 113
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway 113
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 113
Angiogenesis and neoplastic progression in vitro. 113
Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium 113
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo 112
Constitutive and inducible nitric oxide synthase: role in angiogenesis 112
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 112
Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. 111
Growth and motility of microvascular endothelium are modulated by the relative concentration of gangliosides in the medium. 110
Interleukin 1 is an autocrine regulator of human endothelial cell growth 110
Totale 14.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.195
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.319 0 0 0 0 484 386 424 763 426 404 103 329
2020/20214.083 155 445 90 395 180 565 139 647 535 287 312 333
2021/20222.838 187 392 153 349 122 120 133 122 105 327 245 583
2022/20233.805 248 272 497 589 387 778 51 288 406 69 125 95
2023/20242.371 115 50 155 187 62 696 835 56 3 26 16 170
2024/20251.405 88 292 407 301 317 0 0 0 0 0 0 0
Totale 25.385